First Time Loading...

Beam Therapeutics Inc
NASDAQ:BEAM

Watchlist Manager
Beam Therapeutics Inc Logo
Beam Therapeutics Inc
NASDAQ:BEAM
Watchlist
Price: 24.87 USD -1.47% Market Closed
Updated: Jun 16, 2024
Have any thoughts about
Beam Therapeutics Inc?
Write Note

Beam Therapeutics Inc
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beam Therapeutics Inc
Cash Interest Paid Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Beam Therapeutics Inc
NASDAQ:BEAM
Cash Interest Paid
$160k
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Interest Paid
$42m
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
5%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Beam Therapeutics Inc's Cash Interest Paid?
Cash Interest Paid
160k USD

Based on the financial report for Dec 31, 2023, Beam Therapeutics Inc's Cash Interest Paid amounts to 160k USD.

What is Beam Therapeutics Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 3Y
-34%

Over the last year, the Cash Interest Paid growth was -58%. The average annual Cash Interest Paid growth rates for Beam Therapeutics Inc have been -34% over the past three years .